Skip to content
★ Sign in to follow
MM

Maria Margareta Linnéa Jalmelid

IRLAB Therapeutics
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€7,031
▼ Sales (0 ops.)
—

Latest filing published 12 Sept 2019 for IRLAB Therapeutics, €7,031.

Filing timeline

BuySale
Maria Margareta Linnéa Jalmelid

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 12 Sept 2019 · 2614 days ago · €7,031
    +9.9%
    Entry 41.12 · Close at T+365 45.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Maria Margareta Linnéa Jalmelid: trading record in brief

Our data holds just one disclosure by Maria Margareta Linnéa Jalmelid, dated 12 September 2019, reporting an open-market purchase worth €7,031 in IRLAB Therapeutics. Further filings will be added here. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Maria Margareta Linnéa Jalmelid

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief of Clinical OperationsExecutivesIRLAB Therapeutics
    74,916 SEK31FI-SE
    1,916 shares@ SEK 39.10100.0% of flowAktieISIN SE0012675361FI:csv-8287ac8e4485731dc467
    Canonical exit: 11 Dec 2019 (T+90)

1 of 1 declaration